Increased levels of PlGF were reported in obesity-associated pancreatic cancer patients and ablation of the VEGFR-1 signaling in pancreatic ductal adenocarcinoma murine models prevented obesity-induced tumor progression [77]. The gene discussed is PGF; the disease is obesity due to melanocortin 4 receptor deficiency.